Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sen. Hatch FDA legislation

This article was originally published in The Gray Sheet

Executive Summary

Sen. Hatch (R-Utah) is contemplating legislation that would eliminate FDA as it currently exists and create independent device and drug offices under the Public Health Service. Also among ideas under consideration is relocating device center operations to the Senator's home state of Utah, according to staffers. Hatch is considering the measures out of concern that pharmaceutical regulatory concepts will be applied to the device program if the centers are not independent. Staffers plan to begin developing a "concept paper" on potential legislation in late April.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT000421

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel